Iran Specialty Board Psychiatry common mistakes
Iran Specialty Board Psychiatry · Understand the traps and how to avoid them.
When asked to localize a lesion or explain a symptom from a vignette, the candidate names the structure (e.g., 'amygdala') but cannot state the pathway, neurotransmitter, or clinical consequence, so partial-credit items on neuroanatomy/neurochemistry are lost.
Basic-science study is done as isolated fact lists (nuclei, transmitters) without being tied to the clinical syndromes that appear in the vignettes; under time pressure only the label surfaces.
What to do instead
For each major circuit (mesolimbic/mesocortical dopamine, cortico-striato-thalamo-cortical loop, Papez circuit, HPA axis, serotonergic raphe projections), write a one-page card linking anatomy to transmitter, to the symptom it produces when dysregulated, and to the drug class that acts there; rehearse aloud from symptom back to structure.
The candidate labels a mood or psychotic presentation from a single prominent feature (e.g., 'auditory hallucinations = schizophrenia') and ignores duration, functional decline, and exclusion criteria, choosing the superficially matching option.
Pattern-matching to a keyword is faster than running the full DSM-5-TR/ICD-11 criteria set, and exam vignettes deliberately plant a 'seductive' feature that belongs to another disorder.
What to do instead
Before answering any diagnostic item, silently tick the criteria checklist: duration, number of symptom domains, functional impairment, substance/medical exclusion, and prior manic/hypomanic episodes. Practice 20 vignettes where the obvious label is wrong and write why the distractor fails each criterion.
In psychotic-disorder items the candidate cannot separate first-rank/Schneiderian phenomena from mood-congruent psychotic features, catatonia, or dissociative phenomena, and misassigns the diagnosis or the treatment priority.
Phenomenology is memorized as a glossary rather than as a discriminator; catatonia and psychotic depression are under-recognized because motor and mood signs are read as 'severity' rather than as separate syndromes.
What to do instead
Build a two-column discriminator table (schizophrenia spectrum vs. psychotic mood disorders vs. catatonia vs. dissociative) keyed on temporal sequence, mood congruence, motor signs, and response to benzodiazepines/ECT; apply it to every psychotic vignette before selecting.
The candidate manages bipolar depression or mixed features as if it were unipolar depression, choosing an antidepressant-first or antidepressant-monotherapy option, and misses the switch/rapid-cycling risk in the stem.
Depressive symptoms dominate the vignette and the antidepressant option is the most familiar; screening for lifetime hypomania is skipped under time pressure.
What to do instead
Make 'any lifetime period of elevated/irritable mood with increased energy' a mandatory screen on every depression item; memorize the guideline hierarchy (mood stabilizer or atypical antipsychotic first, antidepressant only with a mood stabilizer and never alone in mixed features) and drill switch-risk vignettes.
For OCD, PTSD, and anxiety items the candidate picks a plausible-sounding medication or therapy without matching the first-line evidence (e.g., SSRI dose/duration for OCD, trauma-focused psychotherapy for PTSD, exposure-based CBT for specific phobia) and without knowing the required trial length before declaring failure.
Drug names are recalled but dose ceilings, onset latency, and augmentation steps are not, and exposure-based therapy is confused with supportive therapy.
What to do instead
Create a first-line table per disorder with agent, target dose, minimum trial duration (e.g., 8–12 weeks at adequate dose for OCD), and the evidence-based psychotherapy; memorize the 'what next' step after non-response for each.
In substance-use items the candidate jumps to long-term maintenance (e.g., methadone/buprenorphine or naltrexone) when the stem describes acute intoxication, withdrawal, or a medical emergency, and misses the immediate management step or the contraindication.
Maintenance treatment is the most rehearsed fact, while withdrawal timelines, CIWA scoring, and precipitated-withdrawal risks are learned less thoroughly.
What to do instead
For every SUD vignette, first classify the phase (intoxication, withdrawal, early abstinence, maintenance) and then select treatment; memorize withdrawal onset/duration per substance, the precipitated-withdrawal hazard of buprenorphine/naltrexone, and thiamine/glucose ordering in alcohol-related presentations.
Delirium is misdiagnosed as dementia or as a primary psychiatric disorder because the candidate anchors on the behavioral disturbance and does not establish acute onset with fluctuating attention, and in C-L items the candidate misses the medical/medication cause or the capacity determination.
Vignettes foreground agitation or hallucinations; attention testing and medication review are cognitively skipped, and decisional capacity is confused with 'refusing care'.
What to do instead
Make a four-item delirium screen automatic (acute onset, fluctuating course, inattention, medical/medication trigger), practice the four capacity abilities (understanding, appreciation, reasoning, choice), and review anticholinergic and steroid causes explicitly.
In child/adolescent items the candidate applies adult criteria and adult dosing without adjusting for developmental stage, and misses red flags such as regression, school refusal, or caregiver-related trauma that change the diagnosis or mandate a safeguarding step.
Adult-oriented study habits carry over; developmental norms and the mandatory reporting/safeguarding pathway are less familiar.
What to do instead
Memorize developmental norms for language, attention, and separation anxiety by age band, learn the child-specific first-line options and dosing ranges, and rehearse vignettes where the correct answer is a safeguarding or family-based intervention rather than a drug.
The candidate treats personality disorder, somatic symptom, and dissociative items as exclusionary labels ('nothing else fits') and therefore cannot choose the specific evidence-based psychotherapy or the appropriate crisis/limit-setting response in the stem.
These domains are studied as descriptive lists without treatment mapping, and borderline/antisocial presentations are conflated under 'difficult patient'.
What to do instead
Map each personality cluster and each somatic/dissociative disorder to its evidence-based psychotherapy (e.g., DBT for emotion dysregulation, mentalization-based or schema therapy, CBT for health anxiety) and to the recommended response to self-harm or splitting; drill 10 vignettes where the answer is a therapy modality.
The candidate answers ECT/TMS/psychotherapy and emergency/legal items from general impressions: wrong ECT indication or consent/anaesthetic sequence, wrong seizure-duration or cognitive-effect facts, and in suicide/aggression/ethics items chooses the 'safe' option without applying risk stratification, involuntary-commitment criteria, or confidentiality limits.
Somatic treatments and legal frameworks are memorized as slogans, and emergency items are answered by intuition rather than by a structured risk assessment and the statutory criteria.
What to do instead
Build a one-page sheet per modality (indications, contraindications, consent, adverse effects, monitoring) and a structured suicide-risk template (ideation/plan/intent/means/protective factors → disposition); for ethics/legal items, state the governing principle and the legal criterion before choosing, and drill capacity, confidentiality, and involuntary-admission scenarios.